Platelet-Rich Plasma-Fibrin Glue
Phase 3Small molecule
Platelet-Rich Plasma-Fibrin Glue is one of 47 small molecule programs targeting Treatment. It is currently in Phase 3.
1
Indications
1
Total Trials
1
Active Trials
46
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
350 competitors in Treatment
#DrugCompanyPhaseTrials
1Biltricide
BayerPreclinical
Platelet-Rich Plasma-Fibrin Glue
MMashhad University of Medical Sciences
Phase 3
Dexilant
TakedaPreclinical
Alfenta
Jazz PharmaceuticalsPreclinical
Niclocide
BayerPreclinical
Minipress
PfizerPreclinical
Hivid
CConrado Roberto Hoffmann Filho
Preclinical
Clomid
FerringPreclinical
Aurlumyn
BBTG International Inc.
Preclinical
Lotemax
PPharmos
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details